Williamsville, NY, March 04, 2020 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE AMERICAN: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis plant research, announced that two studies published in Cancer E⦠[+4805 chars]Source